IMS Health Inc. v. Ayotte - What Does it Mean for the Health Care Industry


In November 2008, the United States Court of Appeals for the First Circuit issued a decision upholding a controversial New Hampshire law governing the sale, license, transfer, and use of prescriber-identifiable data in the case IMS Health Inc. v. Ayotte. This decision was widely viewed as a setback both to pharmaceutical companies and to the companies that collect and sell data for use in prescription drug marketing. Although the First Circuit's decision to uphold the New Hampshire law likely will embolden those states considering similar legislation and create a trend toward increased regulation of data sales, the New Hampshire law is unlikely to achieve the desired impact on pharmaceutical companies' prescription drug marketing practices.

In this article, published in BNA Health Law Reporter on December 18, 2008, Mintz Levin attorneys Jennifer Williams and Heather Westphal provide a detailed analysis of the act on the industry, and discuss future legislation which is likely to be enacted in other states.

Please go to this URL to view article:

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Mintz Levin - Health Law & Policy Matters | Attorney Advertising

Written by:


Mintz Levin - Health Law & Policy Matters on:

JD Supra Readers' Choice 2016 Awards
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.